Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.Across the 68 markets, sales ...

Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for ...

Taking tiny doses of GLP-1 medication has been touted for weight management, perimenopause symptoms, even longevity. But is ...

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

ORLANDO, FLA. — Increasing levels of protein and fiber, stressing portion control, and adding savory flavors are ways that ...

Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within o ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss are significantly transforming the fiel ...

Researchers had found in a new study that sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 ...